Tobias, Alexander <br/><br/>
Olaratumab for advanced soft tissue sarcoma.  [electronic resource] 

 -  Expert review of clinical pharmacology  Jul 2017 
 - 699-705 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Review 
<br/><br/><label>ISSN: </label>1751-2441 
<br/><br/><label>Standard No.: </label>10.1080/17512433.2017.1324295  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Humans<br/>Randomized Controlled Trials as Topic<br/>Receptor, Platelet-Derived Growth Factor alpha--immunology<br/>Sarcoma--drug therapy<br/>Survival Rate